| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.26 | 0.07 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.29 | 0.07 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.07 |